These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17883285)

  • 1. Standard and novel therapeutic approaches to Behçet's disease.
    Gul A
    Drugs; 2007; 67(14):2013-22. PubMed ID: 17883285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-Behçet syndrome presenting as acute meningeal syndrome.
    Kara B; Somer A; Pişkin S; Aydinli N; Salman N; Yalçin I
    J Infect; 2006 Apr; 52(4):e120-3. PubMed ID: 16197999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behcet's disease therapy review].
    Vidaller Palacín A; Robert Olalla J; Sanuy Jiménez B; Rufi Rigau G; Folch Civit J; Charte González A
    An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Behçet's disease--an update.
    Kaklamani VG; Kaklamanis PG
    Semin Arthritis Rheum; 2001 Apr; 30(5):299-312. PubMed ID: 11303303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.
    Rotondo C; Lopalco G; Iannone F; Vitale A; Talarico R; Galeazzi M; Lapadula G; Cantarini L
    Mediators Inflamm; 2015; 2015():451675. PubMed ID: 26185360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches to Behçet's disease.
    Sakane T; Takeno M
    Expert Opin Investig Drugs; 2000 Sep; 9(9):1993-2005. PubMed ID: 11060788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
    Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
    Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A child with Behçet's disease presenting with a spectrum of inflammatory manifestations including epididymoorchitis.
    Pektaş A; Devrim I; Beşbaş N; Bilginer Y; Cengiz AB; Ozen S
    Turk J Pediatr; 2008; 50(1):78-80. PubMed ID: 18365598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the symptoms of Behçet's disease.
    Evereklioglu C
    Expert Opin Pharmacother; 2004 Feb; 5(2):317-28. PubMed ID: 14996628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapy for Behçet's disease.
    Goker B; Goker H
    Am J Ther; 2002; 9(5):465-70. PubMed ID: 12237740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behçet's disease; A rare refractory patient with vena cava superior syndrome treated with infliximab: a case report and review of the literature.
    Uyaroglu OA; Erden A; Kilic L; Peynircioğlu B; Karadag O; Kalyoncu U
    Acta Clin Belg; 2019 Oct; 74(5):364-369. PubMed ID: 30220250
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.
    Calgüneri M; Ertenli I; Kiraz S; Erman M; Celik I
    Dermatology; 1996; 192(2):125-8. PubMed ID: 8829493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of vascular Behçet's disease.
    Alibaz-Oner F; Direskeneli H
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():105-108. PubMed ID: 29665281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behçet's syndrome: facts and controversies.
    Mat C; Yurdakul S; Sevim A; Özyazgan Y; Tüzün Y
    Clin Dermatol; 2013; 31(4):352-361. PubMed ID: 23806152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future treatments for Behçet's uveitis: road to remission.
    Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Dick AD; Adán A
    Int Ophthalmol; 2014 Apr; 34(2):365-81. PubMed ID: 23729309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behçet's disease.
    Yesudian PD; Edirisinghe DN; O'Mahony C
    Int J STD AIDS; 2007 Apr; 18(4):221-7. PubMed ID: 17509169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Behçet's disease].
    Comarmond C; Wechsler B; Cacoub P; Saadoun D
    Rev Med Interne; 2014 Feb; 35(2):126-38. PubMed ID: 24438860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches in the treatment of Adamantiades-Behçet's disease.
    Pipitone N; Olivieri I; Cantini F; Triolo G; Salvarani C
    Curr Opin Rheumatol; 2006 Jan; 18(1):3-9. PubMed ID: 16344613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
    Gulli S; Arrigo C; Bocchino L; Morgante L; Sangari D; Castagna I; Bagnato GF
    BMC Musculoskelet Disord; 2003 Aug; 4():19. PubMed ID: 12946278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.